Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Chipmakers Selloff Leads Nasdaq 100 Down 5%
Business & Finance

Chipmakers Selloff Leads Nasdaq 100 Down 5%

Bloomberg Technology Thursday 05 November 2026, 15:56 UTC 1 min read
Key Points

Nov 5th, 2026 Chipmakers Selloff Leads Nasdaq 100 Down 5% Sarah Hunt, Alpine Saxon Woods chief market strategist, reacts to the chipmaker selloff which pulled down the Nasdaq 100 by 5% in early trading on Thursday. Some investors are worried a Democratic sweep of Congress could mean tighter regulation. She speaks on "Bloomberg Open Interest."

Nov 5th, 2026 Chipmakers Selloff Leads Nasdaq 100 Down 5% Sarah Hunt, Alpine Saxon Woods chief market strategist, reacts to the chipmaker selloff which pulled down the Nasdaq 100 by 5% in early trading on Thursday. Some investors are worried a Democratic sweep of Congress could mean tighter regulation. She speaks on "Bloomberg Open Interest."
Sarah Hunt (PERSON) Democratic (ORG) Congress (ORG)
Originally published by Bloomberg Technology Read original →

Related Stories

Discursive Verses: Is 'Spend Dat' the best financial indicator of America's grift economy?

NPR Music culture critic and reporter Rodney Carmichael ruminates on the latest in rap culture. This week: How Yung Miami's summer bop became a sweeping indictment.(Image credit: Aaron J. Thornton/Getty Images for BET)

NPR News 19m ago

The Data Center Fight Is Just Beginning

The Data Center Fight Is Just Beginning Voters across America have not only come out against data centers, but also presented a challenge to the AI billionaires behind them. Victorious Democrats must now contend with that outcome while ensuring US AI labs remain competitive on the global stage, Bloomberg Opinion columnist Dave Lee says.

Bloomberg Markets 21m ago

The year’s most successful stock-market trades are unraveling — perhaps for good

Wall Street’s top trades of 2026 are coming undone as a violent rotation rattles the U.S. stock market.

MarketWatch 26m ago

We're booking big profits in 2 outperformers in Thursday's terrible market

We're locking in hefty profits in two of our growth healthcare positions Thursday. Selling 50 shares of Cardinal Health at roughly $273; Jim Cramer's Charitable Trust will own 375 shares of CAH, decreasing its weighting in the portfolio to 2.75% from 3% Selling 10 shares of Eli Lilly at roughly $1,420; the Trust will own 70 shares of LLY, decreasing its weighting in the portfolio to 2.6% from 3% Healthcare continues to outperform in a market that wants nothing to do with tech and data...

CNBC 27m ago